Evenity

Evenity (romosozumab-aqqg) is prescribed for the treatment of osteoporosis in post-menopausal women who are at high risk for fracture or who cannot use another osteoporosis medication, or for who other medications did not work well. Evenity not only helps prevent further bone loss but also stimulates the formation of new bone.

Evenity is injected subcutaneously by a healthcare professional twice per month for a period of twelve months. Each biweekly dose consists of two injections. Patients may be instructed to take calcium and Vitamin D supplements while receiving Evenity.